logo
Plus   Neg
Share
Email

Thermo Fisher Launches Highly Automated PCR Solution For COVID-19 Testing - Quick Facts

Thermo Fisher Scientific Inc. (TMO) said Wednesday it has unveiled a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day, to meet increasing global demand for COVID-19 testing.

According to the company, the high-throughput system enables laboratories to double or even triple their testing capacity to support global efforts to return communities back to work and school.

The Thermo Fisher Scientific Amplitude Solution is a molecular diagnostic testing system that leverages the company's Applied Biosystems QuantStudio 7 Flex Real-time PCR instruments along with liquid handling products from Tecan Group, a provider of laboratory automation and liquid handling services.

The modular solution delivers test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources, Thermo Fisher noted.

The Amplitude Solution utilizes Thermo Fisher's Applied Biosystems TaqPath COVID-19 Combo Kit, a multiplex diagnostic test that contains the assays and controls needed for the qualitative detection of nucleic acid from SARS-CoV-2, the virus that causes COVID-19.

Thermo Fisher said it will submit this new end-to-end solution to the U.S. Food and Drug Administration for Emergency Use Authorization or EUA and plans to secure additional authorizations globally.

The system also includes instruments from Tecan's Fluent Laboratory Workstation family, the highest-performance platform within its portfolio of liquid-handling solutions for laboratory automation. The Fluent instruments will be supplied through Tecan's Partnering Business.

Thermo Fisher said that as part of this offering, customers of Amplitude Solution will enter into a supply agreement with the company to secure an up-front, confirmed and reliable supply of reagents and consumables.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. tech giant Google is laying the groundwork for a fiber-optic network that will connect the first time through Saudi Arabia and Israel, opening a new global internet traffic corridor, the Wall Street Journal reported, citing people familiar with the plans. The link would be established as part of an optical-fiber cable line connecting Europe with India. U.S. retailers Best Buy Co. Inc., Abercrombie & Fitch Co., and Dollar Tree Inc. on Tuesday reported results for the third quarter that surpassed analysts' expectations. The upbeat results indicate that retailers have largely recovered from the impact of the coronavirus pandemic just as the holiday season approaches. The companies have also intensified their focused on digital sales. The U.S. Food and Drug Administration approved the first drug to treat primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder which causes recurrent kidney stones and loss of kidney function. Alnylam Pharmaceuticals' Oxlumo (lumasiran) in the form of injection lowers urinary oxalate levels in pediatric and adult patients.
Follow RTT